ADAR1 Capital Management »

Longboard Pharmaceuticals In shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Longboard Pharmaceuticals In (LBPH) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Longboard Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Longboard Pharmaceuticals In held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Longboard Pharmaceuticals In by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $99k 4.6k 21.60
2023-12-31 $4.8k 800 6.03

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Longboard Pharmaceuticals In

Farallon Capital Management
T. Rowe Price Associates
BlackRock
Cormorant Asset Management
BlackRock
Viking Global Investors
Vanguard Group
Woodline Partners
Pictet Asset Management Holding SA
Jennison Associates
Siren
State Street Corporation
Geode Capital Management
Driehaus Capital Management
Parkman Healthcare Partners

View all funds holding Longboard Pharmaceuticals In